Delivery Order SPE2DB24D2101-SPE2DB25FKPRH
- Not listed
- The Defense Logistics Agency awarded a $1,396.34 delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed-price, non-set-aside contract with a completion date of September 10, 2025, and performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX,...
- The Defense Logistics Agency awarded a $5,863.86 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of August 21, 2025. The product will be delivered to the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC)...
- The Defense Logistics Agency awarded a $14,320.27 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens. The award is not set-aside and will be completed by September 23, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $1,150.32 delivery order to AmerisourceBergen Drug Corp for NovoLog 100 Unit/mL FlexPen 3mL insulin pens on September 16, 2025, with completion expected by September 17, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of NovoLog Mix 70/30 FlexPen 3mL insulin pens. This competitively awarded, firm fixed-price delivery order has a ceiling value of $1,342.84 with an ultimate completion date of September 8, 2025. The contract represents a non-set-aside procurement issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $1,725.61 to AmerisourceBergen Drug Corp for NovoLog Mix 70-30 FlexPen 3ml insulin pens on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and is being performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen Drug Corp's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 23, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens, valued at $8,434.80. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 24, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens, a widely-used combination insulin product for diabetes management. This firm fixed-price delivery order, valued at $1,252.30, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which carries a potential value of $999,999,999.00 through...
- The Defense Logistics Agency awarded a $2,217.78 delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3ml insulin pens. This is a firm fixed price, competitively awarded contract with a completion date of July 21, 2025, and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement. The product will be delivered to the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a $2,661.40 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of NovoLog 100 Unit/mL FlexPen 3mL insulin pens. This contract represents a competitive, non-set-aside award under a firm fixed-price arrangement with an ultimate completion date of August 18, 2025. The pharmaceutical product will be delivered to the place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters....
- SPE2DB24D2101Indefinite Delivery Contract
- SPE2DB24D2101-SPE2DB25FKPRHDelivery Order
The Defense Logistics Agency awarded a $3,791.46 delivery order to AmerisourceBergen Drug Corp on September 17, 2025, for the supply of NovoLog Mix 70-30 FlexPen 3mL insulin pens. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of September 18, 2025, and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX). The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor headquartered in Pennsylvania that serves as a critical federal medical procurement vendor, particularly for military and veteran healthcare systems. The company holds a $1 billion IDC through December 2026 that enables it to supply a comprehensive range of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. This delivery order for insulin pens exemplifies the company's role in supplying essential diabetes medications and specialty pharmaceuticals to federal healthcare programs through competitively awarded, firm fixed-price transactions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 9/17/25 |